ORX:STO
Orexo AB
SEK 0.98
arrow_downward
-1.80%(-0.018) 1D
Nov 20, 11:49:10 AM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 1.05
High
SEK 1.05
Low
SEK 0.93
Mkt. cap
343.58M
Avg. vol.
785.30K
Volume
161.65K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.05
High
SEK 1.05
Low
SEK 0.93
Mkt. cap
343.58M
Avg. vol.
785.30K
Volume
161.65K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Bitcoin Is 35% Below Its 52-Week High While the S&P 500 Is Up. Here’s What That Says About the Digital Gold Thesis.
MarketWatch
·
42 minutes ago
Here’s what happened next after previous times the S&P 500 losing streak reached six sessions
Benzinga
·
41 minutes ago
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Weighs Iran Decision— INTU, ROST, KEYS in Focus
MarketForces Africa
·
2 hours ago
S&P 500, Nasdaq, Dow Jones Dip Amidst Anthropic IPO Debut
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com